US Patent Issued to CorFlow Therapeutics on July 21 for "Controlled flow infusion microvascular dysfunction diagnostic and therapy" (Swiss, American Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,448, issued on July 21, was assigned to CorFlow Therapeutics AG (Baar, Switzerland).

"Controlled flow infusion microvascular dysfunction diagnostic and therapy" was invented by Robert S. Schwartz (Inver Grover Heights, Minn.), Jon Helge Hoem (Baar, Switzerland), Sabrina Frey (Bern, Switzerland) and Oliver Bludau (Baar, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and systems are provided for diagnosis and/or treatment of microvascular dysfunction, such as microvascular obstruction (MVO), in which the effects of collateral flow around a treatment site are addressed by injecting volumetric flows into a vessel using an infusion sy...